SCHEMBL27448755

SCHEMBL27448755

CC(C)(C)OC(=O)NC1CCN(c2cc(OCc3ccccc3)cc(Cl)n2)CC1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 3/20 0.57
▸ SKP1 P63208 3/20 0.57
▸ SKP2 Q13309 3/20 0.57
▸ KMT2A Q03164 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ SUV39H2 Q9H5I1 2/20 0.45
▸ MAPK8 P45983 1/20 0.45
▸ BTK Q06187 1/20 0.45
▸ CNR1 P21554 1/20 0.44
▸ CNR2 P34972 1/20 0.44
▸ KCNA3 P22001 1/20 0.44
▸ MCL1 Q07820 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.43
▸ PRMT5 O14744 2/20 0.42
▸ DRD2 P14416 2/20 0.42
▸ SLC6A5 Q9Y345 1/20 0.42
▸ DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29998568 1.00 CKS1B (0.57) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL27451694 0.85 CKS1B (0.53) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL21564567 0.84 CKS1B (0.60) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL30931783 0.84 CKS1B (0.60) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL27449378 0.83 SUV39H2 (0.53) CKS1BSKP1SKP2SUV39H2BTK
SCHEMBL21564375 0.82 CKS1B (0.56) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL32665202 0.82 CKS1B (0.52) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL12321963 0.81 CKS1B (0.53) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL21390074 0.81 CKS1B (0.50) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL29998716 0.80 CKS1B (0.48) CKS1BSKP1SKP2SUV39H2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF KDM1A, TET1, KDM3A CKS1B 808/4885SKP1 331/4885SKP2 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback